|
ZNF605 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08246744900953E-13 |
| Normal-vs-Stage2 |
1.6804999947162E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
6.16118267515731E-12 |
| Stage1-vs-Stage2 |
4.770600E-01 |
| Stage1-vs-Stage3 |
5.277900E-02 |
| Stage1-vs-Stage4 |
1.907580E-01 |
| Stage2-vs-Stage3 |
2.956400E-02 |
| Stage2-vs-Stage4 |
7.828400E-02 |
| Stage3-vs-Stage4 |
9.322400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
2.95210000000878E-06 |
| Normal-vs-Asian |
3.18539999999423E-06 |
| Caucasian-vs-AfricanAmerican |
2.711000E-01 |
| Caucasian-vs-Asian |
4.082600E-03 |
| AfricanAmerican-vs-Asian |
3.008800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54765089632747E-13 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
5.807200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62547753035369E-12 |
| Normal-vs-Age(41-60Yrs) |
9.45687972375708E-13 |
| Normal-vs-Age(61-80Yrs) |
1.64834812466097E-12 |
| Normal-vs-Age(81-100Yrs) |
2.15169999999709E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.965200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.538600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.500000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.853800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.012200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.550800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.00090000000075E-05 |
| Classical-VS-Follicular |
3.500300E-02 |
| Classical-VS-Other |
9.667800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.00400000005541E-06 |
| Tall-VS-Other |
1.773960E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.301800E-01 |
| Follicular-VS-Normal |
4.79809999998082E-06 |
| Other-VS-Normal |
2.099200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39808173319034E-14 |
| Normal-vs-N1 |
1.64790403545112E-12 |
| N0-vs-N1 |
9.666300E-02 |
|
|
